Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22
Phase 31

Trial Status

Terminated1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03741712Phase 1/2Terminated
A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC
Castration-resistant Prostate CancerProstate Cancer
PrincipalinvestigatorStart date: 2018-11-20
NCT03520478Phase 3Unknown
A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer
Hormone-Dependent Prostate CancerProstate Cancer
PrincipalinvestigatorStart date: 2018-05-30
NCT02691975Phase 1/2Unknown
A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients
Hormone Refractory Prostate CancerMetastatic Prostate Carcinoma
PrincipalinvestigatorStart date: 2016-04-12

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03741712Phase 1/2PrincipalInvestigator

A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC

Castration-resistant Prostate CancerProstate Cancer
Terminated
NCT03520478Phase 3PrincipalInvestigator

A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer

Hormone-Dependent Prostate CancerProstate Cancer
Unknown
NCT02691975Phase 1/2PrincipalInvestigator

A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients

Hormone Refractory Prostate CancerMetastatic Prostate Carcinoma
Unknown

All 3 trials loaded